Valproate is metabolized via carnitine-acylcarnitine translocase, massively increasing carnitine demand. Simultaneously, valproate impairs carnitine biosynthesis and renal tubular reabsorption. Carnitine deficiency from valproate is associated with potentially fatal hyperammonemic encephalopathy.
Raskind & El-Chaar (Ann Pharmacother, 2000) — carnitine deficiency in 50–70% of valproate-treated children; adults also affected. FDA recommends carnitine supplementation in valproate patients with hepatotoxicity or hyperammonemia. Coulter (J Child Neurol, 1991) — carnitine prevents valproate-induced hepatotoxicity.
Hyperammonemia (confusion, lethargy), hepatotoxicity, nausea, fatigue, muscle weakness
L-Carnitine 1,000–3,000mg daily in divided doses. This is one of the strongest drug-nutrient interactions in medicine — consider prophylactic supplementation in all valproate patients.
View on Fullscript: Jarrow L-Carnitine 500mgDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Valproate is a known depletant of selenium via increased urinary excretion and impaired selenoprotein synthesis. Selenium deficiency from valproate is associated with pancreatitis and immune suppression — side effects that are commonly attributed to the drug rather than the induced deficiency.
Musselman et al. (Acta Neurol Scand, 1995) — significantly lower selenium in valproate-treated patients vs. controls. Navarro-Alarcon et al. — selenium deficiency confirmed in epileptic children on valproate.
Pancreatitis risk, immune suppression, thyroid dysfunction, oxidative stress
Selenium 100–200mcg daily (selenomethionine). Monitor — do not exceed 400mcg/day.
View on Fullscript: Life Extension Super Selenium ComplexDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Valproate forms complexes with zinc in the GI tract, reducing zinc absorption. Increased urinary zinc excretion is also documented. Zinc deficiency from valproate is associated with hair loss (a common valproate complaint) and impaired immune function.
Kaji et al. (Brain Dev, 1992) — significantly lower serum zinc in valproate-treated patients. Hair loss from valproate is clinically reduced by zinc supplementation — hair follicle matrix cells have high zinc turnover.
Hair loss (alopecia), impaired wound healing, immune suppression, taste/smell changes
Zinc picolinate 25–30mg daily with food. Balance with 1–2mg copper for long-term use. Zinc supplementation is clinically validated for valproate-induced hair loss.
View on Fullscript: Thorne Zinc PicolinateDiscuss with your physician before adjusting supplementation. This is educational content, not medical advice.
Taking Valproate / Valproic Acid? Build Your Replenishment Stack.
Our clinical intake tool accounts for your medications, health goals, and risk factors — and outputs a personalized supplement protocol rated against published clinical trials.
Open the Full Tool Suite